About Pharmacovigilance
Market
Intensifying regulatory
expectations, tougher inspection system, and instant need for patient
reporting boost the adoption rate of pharmacovigilance among
pharmaceutical companies. Rise in the prevalence of acute and chronic
diseases has consequently led to an increase in the incidences of
drug consumption, thus leading to growth in the number of adverse
drug events and drug toxicity cases. Furthermore, safety regulations,
risk of high-profile safety issues, large volume of post-market
events to be reviewed along with negative media coverage have bound
the pharmaceutical players to take support of various outsourcing
services for drug monitoring. Two major outsourcing providers
preferred by pharmaceutical manufacturers for pharmacovigilance
services are namely, traditional CROs (e.g. Covance, Inc., Quintiles
Transnational, INC Research, etc.) and BPOs (e.g. Capgemini,
Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.).
Outsourcing services do not only help in cost saving, but also
support process efficiency. Pharmaceutical companies are now entering
into long-term partnerships/service agreements with CROs and BPOs to
reduce the pharmacovigilance process related expenditure, incurred
right from drug discovery to post-marketing approvals. In addition,
pharmacovigilance requires skilled resources with excellent language
skills and strong knowledge pertaining to case reporting due to which
pharmaceutical companies are opting for outsourced pharmacovigilance
services in order to reduce the burden of clerical functions as well
as capital expenditures.
View Report at :
http://www.marketresearchreports.biz/analysis/180425
This report provides a
detailed analysis of the global pharmacovigilance market and assists
in understanding various market regulating factors. The market
overview section in this report provides analysis of the overall
market trends and market dynamics such as market driving factors,
restraining factors, and opportunities, which currently administrate
the dynamics of the overall pharmacovigilance market. Additionally,
the segment also provides and predicts the future circumstances of
the market. Market monitoring tools such as Porter’s five forces
analysis is also included in this study to provide analysis about the
competition in the pharmacovigilance market and market attractiveness
in various regions across the world. Competitive analysis tools such
as market share analysis and market attractive analysis have also
been included in the market overview section of the report to deliver
a comprehensive status of the players in the global pharmacovigilance
market. The executive summary provided in this report reflects the
highlights of the study scope and the overall market in a summarized
form. Furthermore, it includes a market snapshot, which provides a
glance at the current scenario of the global pharmacovigilance market
in terms of current and future market size and growth.
The global pharmacovigilance
market is segmented on the basis of clinical trial phases, type of
methods, service providers, and geography. Based on clinical trial
phases, the pharmacovigilance market is segmented into preclinical
studies, phase I trial, phase II trial, phase III trial, and phase IV
trial (post marketing surveillance). Based on the methods, this study
segments the market into spontaneous reporting, targeted reporting,
cohort event monitoring, Intensified ADR, and Reporting EHR mining.
Based on service providers, the global pharmacovigilance market is
categorized into in-house and contract outsourcing. The market size
estimations for the period from 2012 to 2020 have been provided for
each segment in terms of USD million. Compounded annual growth rates
(CAGR %) for each segment has been provided for the period between
2014 and 2020, considering 2013 as the base year.
Download Sample copy of
this Report @
In terms of regional analysis,
the global pharmacovigilance market has been segmented into four key
geographies: North America, Europe, Asia Pacific, and Rest of World
(RoW). Market revenue estimations for each of these geographies have
been provided in the report for the period from 2012 to 2020 in terms
of USD million, considering 2013 as the base year for calculations
and 2012 as the historical year. The CAGR (%) of each market segment
for the forecast period from 2014 to 2020 has also been provided
along with market size estimations. This study also provides
recommendations for players of the global pharmacovigilance market,
which include aspects that may play a decisive role in improving the
market share.
The report concludes with
in-depth profiles of leading players, which include key information
about the major organizations dynamically involved in the global
pharmacovigilance market. The report profiles the key market players
in terms of company overview, financial overview, product portfolio,
business strategies, and recent developments. The key companies
profiled in this study are Accenture, Plc, Clinquest Group B.V.,
Cognizant Technology Solutions, Covance, Inc. ICON, Plc, iMED Global
Corporation, inVentiv Health, Inc., Parexel International
Corporation, Pharmaceutical Product Development LLC, PRA Health
Sciences, Inc., Quintiles Transnational Holdings Inc, F. Hoffmann-La
Roche Ltd., Sanofi , Synowledge LLC, Wipro Limited. Market share
analysis of the organizations operating in the pharmacovigilance
market would help new entrants to understand key business policies
and identify product portfolio of established companies.
The global
pharmacovigilance market is segmented as follows:
Pharmacovigilance Market,
by Phases of Drug Development
Preclinical Studies
Phase I
Phase II
Phase III
Phase IV or Post Marketing
Surveillance
Pharmacovigilance Market,
by Type of Methods
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous
Reporting
Cohort Event Monitoring
EHR Mining
Pharmacovigilance Market,
by Type of Service
In-House
Contract Outsourcing
Pharmacovigilance Market,
by Geography
North America
Europe
Asia Pacific
Read our latest Press Release at
http://www.marketresearchreports.biz/pressreleases
Table
of Content :
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global
Pharmacovigilance Market Dynamics
3.1 Introduction
3.2 Market Drivers
3.2.1 Increasing Consumption
of Drugs Would Fuel Demand for Continuous Drug Event Monitoring
3.2.2 Rise in the Cases of
Adverse Drug Reactions and Drug Toxicity Would Boost Demand for
Pharmacovigilance Activities
3.2.3 Rise in Adoption of
Outsourcing Services Expected to Accentuate the Market Growth
3.3 Market Restraints
About us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment